Monashee Investment Management’s Bionano Genomics, Inc. Warrant BNGOW Stock Holding History

Monashee Investment Management’s Portfolio BNGOW Stock Details BNGOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-70,621	Closed	-$148K	–	453
2020 Q4	$148K	Hold	70,621	–	–	0.02%	233
2020 Q3	$16K	Hold	70,621	–	–	﹤0.01%	172
2020 Q2	$9K	Hold	70,621	–	–	﹤0.01%	198
2020 Q1	$7K	Hold	70,621	–	–	﹤0.01%	61
2019 Q4	$23K	Sell	70,621 -92,644	-57%	-$15.7K	0.02%	72
2019 Q3	$100K	Hold	163,265	–	–	0.05%	101
2019 Q2	$119K	Hold	163,265	–	–	0.03%	150
2019 Q1	$188K	Hold	163,265	–	–	0.04%	124
2018 Q4	$205K	Buy	+163,265	New	+$403K	0.14%	72
2018 Q3	–	Hold	0	–	–	–	134

Other funds holding BNGOW

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Monashee Investment Management's BNGOW Position: Q1 2021 in Review

Monashee Investment Management sold out of Bionano Genomics, Inc. Warrant (BNGOW) in Q1 2021, closing a stake of 70,621 shares — an estimated $148K sold.

Monashee Investment Management first reported a position in BNGOW in Q4 2018 and held it in 9 quarters. The position peaked at $205K in Q4 2018. 3 funds tracked by Wall St. Rank hold BNGOW as of Q1 2021.

Monashee Investment Management reported no remaining Bionano Genomics, Inc. Warrant position as of Q1 2021 after selling out during the quarter.
Monashee Investment Management sold 70,621 Bionano Genomics, Inc. Warrant shares in Q1 2021, an estimated $148K.
Monashee Investment Management first reported a position in Bionano Genomics, Inc. Warrant in Q4 2018 and held it in 9 quarters.
Monashee Investment Management's Bionano Genomics, Inc. Warrant position peaked at $205K in Q4 2018.
3 funds tracked by Wall St. Rank held Bionano Genomics, Inc. Warrant as of Q1 2021.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.